Mizuho Markets Americas LLC Decreases Stake in GE HealthCare Technologies Inc. $GEHC

Mizuho Markets Americas LLC trimmed its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 38.5% in the third quarter, Holdings Channel.com reports. The firm owned 3,209,000 shares of the company’s stock after selling 2,009,000 shares during the quarter. GE HealthCare Technologies comprises approximately 4.5% of Mizuho Markets Americas LLC’s investment portfolio, making the stock its 6th biggest position. Mizuho Markets Americas LLC’s holdings in GE HealthCare Technologies were worth $240,996,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in GEHC. Allianz SE grew its stake in shares of GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after buying an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. grew its position in GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after acquiring an additional 196 shares during the last quarter. Godsey & Gibb Inc. acquired a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Gladwyn Financial Advisors Inc. acquired a new position in GE HealthCare Technologies in the 2nd quarter worth about $34,000. Finally, Piscataqua Savings Bank raised its position in GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after purchasing an additional 300 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the subject of several recent research reports. Bank of America upped their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Morgan Stanley raised their price target on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Jefferies Financial Group lifted their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Finally, Wells Fargo & Company decreased their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a report on Thursday, October 30th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Hold” and an average target price of $89.83.

GE HealthCare Technologies Stock Down 0.9%

Shares of NASDAQ GEHC opened at $81.75 on Monday. The company’s 50 day moving average price is $81.29 and its 200-day moving average price is $77.05. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a market capitalization of $37.24 billion, a P/E ratio of 16.89, a price-to-earnings-growth ratio of 3.18 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.